NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.

Keywords {🔍}

cells, apoptosis, trailr, trail, cll, article, cell, figure, google, scholar, cas, apoltrail, hgsetr, depsipeptide, caspase, patients, valproate, ngml, hdaci, trailinduced, trailhisle, death, signaling, surface, trailhis, expression, receptor, agonistic, receptors, data, human, preparations, ligand, clinical, tumor, cancer, nature, lymphocytic, mabs, primary, processing, chronic, shown, sensitization, primarily, activity, leukemia, forms, results, lines,

Topics {✒️}

nature portfolio permissions reprints tnf-related apoptosis-inducing ligand privacy policy epstein–barr virus-negative burkitt' nature 364 nature related apoptosis-inducing ligand tumour-necrosis factor superfamily advertising tumour necrosis factor histone deacetylase inhibitors related b-cell malignancies death-inducing signaling complex b-cell prolymphocytic leukemia chronic lymphocytic leukaemia development chronic lymphocytic leukemia isotype-matched control antibody conjugated mouse anti-dr4 anti-trail receptor antibodies social media regulate agonist-specific mechanisms materials media death receptor-induced apoptosis author correspondence expresses primarily trail-r1 adaptor molecule fadd/mort1 tumor cell lines permissions express surface trail-r2 histone deacetylase trail-r1 decreased markedly potentiating trail-induced-apoptosis potentiated trail-induced apoptosis primary tumor signals cell surface trail-r2 temperature-sensitive differential affinity cytotoxic ligand trail trail-r1-selective variants primary tumor cells apo2l/trail signals primarily recombinant apo2l/trail versions apoptosis-inducing ability sensitize tumor cells agonistic trail-r1 ab anti-fas antibody distinct caspase cascades cell death differ trail-r2 increased markedly

Questions {❓}

• Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
         description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
         datePublished:2005-04-29T00:00:00Z
         dateModified:2005-04-29T00:00:00Z
         pageStart:773
         pageEnd:782
         sameAs:https://doi.org/10.1038/sj.cdd.4401649
         keywords:
            chronic lymphocytic leukaemia
            tumor necrosis factor-apoptosis inducing ligand
            TRAIL-R1
            histone deacetylase inhibitors
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Stem Cells
            Apoptosis
            Cell Cycle Analysis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
         isPartOf:
            name:Cell Death & Differentiation
            issn:
               1476-5403
               1350-9047
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M MacFarlane
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S Inoue
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S L Kohlhaas
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Majid
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Harper
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D B J Kennedy
               affiliation:
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M J S Dyer
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G M Cohen
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
      description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
      datePublished:2005-04-29T00:00:00Z
      dateModified:2005-04-29T00:00:00Z
      pageStart:773
      pageEnd:782
      sameAs:https://doi.org/10.1038/sj.cdd.4401649
      keywords:
         chronic lymphocytic leukaemia
         tumor necrosis factor-apoptosis inducing ligand
         TRAIL-R1
         histone deacetylase inhibitors
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Stem Cells
         Apoptosis
         Cell Cycle Analysis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
      isPartOf:
         name:Cell Death & Differentiation
         issn:
            1476-5403
            1350-9047
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M MacFarlane
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S Inoue
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S L Kohlhaas
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Majid
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Harper
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D B J Kennedy
            affiliation:
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M J S Dyer
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G M Cohen
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Differentiation
      issn:
         1476-5403
         1350-9047
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M MacFarlane
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S Inoue
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S L Kohlhaas
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:A Majid
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:N Harper
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:D B J Kennedy
      affiliation:
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:M J S Dyer
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:G M Cohen
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(123)

• How much does http://www.ncbi.nlm.nih.gov/BLAST/ pull in monthly?
• Revenue of http://www.ebi.ac.uk/clustalw/
• What's the financial outcome of https://doi.org/10.1172%2FJCI6926?
• How much does http://scholar.google.com/scholar_lookup?&title=Safety%20and%20antitumor%20activity%20of%20recombinant%20soluble%20Apo2%20ligand&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI6926&volume=104&pages=155-162&publication_year=1999&author=Ashkenazi%2CA&author=Pai%2CRC&author=Fong%2CS&author=Leung%2CS&author=Lawrence%2CDA&author=Marsters%2CSA&author=Blackie%2CC&author=Chang%2CL&author=McMurtrey%2CAE&author=Hebert%2CA&author=DeForge%2CL&author=Koumenis%2CIL&author=Lewis%2CD&author=Harris%2CL&author=Bussiere%2CJ&author=Koeppen%2CH&author=Shahrokh%2CZ&author=Schwall%2CRH pull in?
• Find out how much https://doi.org/10.1016%2F1074-7613%2895%2990057-8 earns monthly
• Revenue of http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-682&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ&author=Din%2CWS&author=Huang%2CCP&author=Nicholl%2CJK&author=Sutherland%2CGR&author=Smith%2CTD&author=Rauch%2CC&author=Smith%2CCA&author=Goodwin%2CRG
• How much income does https://doi.org/10.1074%2Fjbc.271.22.12687 have?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20Apo-2%20ligand%2C%20a%20new%20member%20of%20the%20tumor%20necrosis%20factor%20cytokine%20family&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.271.22.12687&volume=271&pages=12687-12690&publication_year=1996&author=Pitti%2CRM&author=Marsters%2CSA&author=Ruppert%2CS&author=Donahue%2CCJ&author=Moore%2CA&author=Ashkenazi%2CA?
• What's the total monthly financial gain of https://doi.org/10.1038%2F5517?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat.%20Med.&doi=10.1038%2F5517&volume=5&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM&author=Chin%2CW&author=Jones%2CJ&author=Woodward%2CA&author=Le%2CT&author=Smith%2CC&author=Smolak%2CP&author=Goodwin%2CRG&author=Rauch%2CCT&author=Schuh%2CJC&author=Lynch%2CDH?
• How much does https://doi.org/10.1038%2F35008667 earn?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=TRAIL%20receptor-2%20signals%20apoptosis%20through%20FADD%20and%20caspase-8&journal=Nat.%20Cell%20Biol.&doi=10.1038%2F35008667&volume=2&pages=241-243&publication_year=2000&author=Bodmer%2CJL&author=Holler%2CN&author=Reynard%2CS&author=Vinciguerra%2CP&author=Schneider%2CP&author=Juo%2CP&author=Blenis%2CJ&author=Tschopp%2CJ?
• Discover the revenue of https://doi.org/10.1016%2FS1074-7613%2800%2980212-5
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL-dependent%20recruitment%20of%20endogenous%20FADD%20and%20caspase-8%20to%20death%20receptors%204%20and%205&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980212-5&volume=12&pages=611-620&publication_year=2000&author=Kischkel%2CFC&author=Lawrence%2CDA&author=Chuntharapai%2CA&author=Schow%2CP&author=Kim%2CKJ&author=Ashkenazi%2CA?
• What's the financial outcome of https://doi.org/10.1016%2FS1074-7613%2800%2980211-3?
• How much money does http://scholar.google.com/scholar_lookup?&title=FADD%2FMORT1%20and%20caspase-8%20are%20recruited%20to%20TRAIL%20receptors%201%20and%202%20and%20are%20essential%20for%20apoptosis%20mediated%20by%20TRAIL%20receptor%202&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980211-3&volume=12&pages=599-609&publication_year=2000&author=Sprick%2CMR&author=Weigand%2CMA&author=Rieser%2CE&author=Rauch%2CCT&author=Juo%2CP&author=Blenis%2CJ&author=Krammer%2CPH&author=Walczak%2CH make?
• Earnings of https://doi.org/10.1006%2Fexcr.2000.4835
• How much does http://scholar.google.com/scholar_lookup?&title=Protein%20complexes%20activate%20distinct%20caspase%20cascades%20in%20death%20receptor%20and%20stress-induced%20apoptosis&journal=Exp.%20Cell%20Res.&doi=10.1006%2Fexcr.2000.4835&volume=256&pages=27-33&publication_year=2000&author=Bratton%2CSB&author=MacFarlane%2CM&author=Cain%2CK&author=Cohen%2CGM rake in every month?
• Monthly income for https://doi.org/10.1038%2Fnrc821
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumour-necrosis%20factor%20superfamily&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc821&volume=2&pages=420-430&publication_year=2002&author=Ashkenazi%2CA
• How much cash flow does https://doi.org/10.1126%2Fscience.281.5381.1305 have monthly?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Death%20receptors%3A%20signaling%20and%20modulation&journal=Science&doi=10.1126%2Fscience.281.5381.1305&volume=281&pages=1305-1308&publication_year=1998&author=Ashkenazi%2CA&author=Dixit%2CVM?
• How much does https://doi.org/10.1038%2Fsj.cdd.4401187 make?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL%20and%20its%20death%20and%20decoy%20receptors&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401187&volume=10&pages=66-75&publication_year=2003&author=LeBlanc%2CHN&author=Ashkenazi%2CA
• Learn about the earnings of https://doi.org/10.1038%2F75045
• How profitable is http://scholar.google.com/scholar_lookup?&title=Apoptosis%20induced%20in%20normal%20human%20hepatocytes%20by%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand&journal=Nat.%20Med.&doi=10.1038%2F75045&volume=6&pages=564-567&publication_year=2000&author=Jo%2CM&author=Kim%2CTH&author=Seol%2CDW&author=Esplen%2CJE&author=Dorko%2CK&author=Billiar%2CTR&author=Strom%2CSC?
• What's the monthly income of https://doi.org/10.1046%2Fj.1365-2141.2000.02404.x?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20tumour%20necrosis%20factor%20%28TNF%29-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20receptors%20and%20sensitivity%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B-cell%20acute%20lymphoblastic%20leukaemia%20cells&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2000.02404.x&volume=111&pages=580-586&publication_year=2000&author=Clodi%2CK&author=Wimmer%2CD&author=Li%2CY&author=Goodwin%2CR&author=Jaeger%2CU&author=Mann%2CG&author=Gadner%2CH&author=Younes%2CA bring in?
• What's the total monthly financial gain of https://doi.org/10.1038%2Fsj.onc.1205853?
• Get to know http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B%20cell%20chronic%20lymphocytic%20leukaemia&journal=Oncogene&doi=10.1038%2Fsj.onc.1205853&volume=21&pages=6809-6818&publication_year=2002&author=MacFarlane%2CM&author=Harper%2CN&author=Snowden%2CRT&author=Dyer%2CMJ&author=Barnett%2CGA&author=Pringle%2CJH&author=Cohen%2CGM's earnings
• https://doi.org/10.1046%2Fj.1365-2141.1997.4393250.x's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Activity%20of%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20in%20haematological%20malignancies&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.1997.4393250.x&volume=99&pages=618-624&publication_year=1997&author=Snell%2CV&author=Clodi%2CK&author=Zhao%2CS&author=Goodwin%2CR&author=Thomas%2CEK&author=Morris%2CSW&author=Kadin%2CME&author=Cabanillas%2CF&author=Andreeff%2CM&author=Younes%2CA gross monthly?
• How much profit is https://doi.org/10.1016%2Fj.drup.2004.03.002 making per month?
• http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20therapeutic%20potential%20of%20TRAIL%20by%20cancer%20chemotherapy%20and%20irradiation%3A%20mechanisms%20and%20clinical%20implications&journal=Drug%20Resist.%20Update&doi=10.1016%2Fj.drup.2004.03.002&volume=7&pages=139-156&publication_year=2004&author=Shankar%2CS&author=Srivastava%2CRK's financial summary
• https://doi.org/10.1038%2Fsj.cdd.4401535's total income per month
• http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20inhibitors%20potentiate%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29-induced%20apoptosis%20in%20lymphoid%20malignancies&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401535&volume=11&issue=Suppl%202&pages=S193-206&publication_year=2004&author=Inoue%2CS&author=MacFarlane%2CM&author=Harper%2CN&author=Wheat%2CLM&author=Dyer%2CMJ&author=Cohen%2CGM's total income per month
• How much money does https://doi.org/10.1038%2F35106079 generate?
• http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20and%20cancer%3A%20causes%20and%20therapies&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2F35106079&volume=1&pages=194-202&publication_year=2001&author=Marks%2CP&author=Rifkind%2CRA&author=Richon%2CVM&author=Breslow%2CR&author=Miller%2CT&author=Kelly%2CWK's total income per month
• Get to know what's the income of https://doi.org/10.1016%2FS1471-4892%2803%2900084-5
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases&journal=Curr.%20Opin.%20Pharmacol.&doi=10.1016%2FS1471-4892%2803%2900084-5&volume=3&pages=344-351&publication_year=2003&author=Marks%2CPA&author=Miller%2CT&author=Richon%2CVM?
• What's https://doi.org/10.1074%2Fjbc.M409578200's gross income?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20C-terminal%20tails%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20and%20Fas%20receptors%20have%20opposing%20functions%20in%20Fas-associated%20Death%20Domain%20%28FADD%29%20recruitment%20and%20can%20regulate%20agonist-specific%20mechanisms%20of%20receptor%20activation&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M409578200&volume=279&pages=52479-52486&publication_year=2004&author=Thomas%2CLR&author=Johnson%2CRL&author=Reed%2CJC&author=Thorburn%2CA?
• Check the income stats for https://doi.org/10.1074%2Fjbc.272.41.25417
• How profitable is http://scholar.google.com/scholar_lookup?&title=Identification%20and%20molecular%20cloning%20of%20two%20novel%20receptors%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.272.41.25417&volume=272&pages=25417-25420&publication_year=1997&author=MacFarlane%2CM&author=Ahmad%2CM&author=Srinivasula%2CSM&author=Fernandes-Alnemri%2CT&author=Cohen%2CGM&author=Alnemri%2CES?
• How much money does https://doi.org/10.1074%2Fjbc.M101287200 generate?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20is%20a%20direct%20target%20of%20valproic%20acid%2C%20a%20potent%20anticonvulsant%2C%20mood%20stabilizer%2C%20and%20teratogen&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M101287200&volume=276&pages=36734-36741&publication_year=2001&author=Phiel%2CCJ&author=Zhang%2CF&author=Huang%2CEY&author=Guenther%2CMG&author=Lazar%2CMA&author=Klein%2CPS?
• How much does https://doi.org/10.1093%2Femboj%2F20.24.6969 net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Valproic%20acid%20defines%20a%20novel%20class%20of%20HDAC%20inhibitors%20inducing%20differentiation%20of%20transformed%20cells&journal=EMBO%20J.&doi=10.1093%2Femboj%2F20.24.6969&volume=20&pages=6969-6978&publication_year=2001&author=Gottlicher%2CM&author=Minucci%2CS&author=Zhu%2CP&author=Kramer%2COH&author=Schimpf%2CA&author=Giavara%2CS&author=Sleeman%2CJP&author=Lo%20Coco%2CF&author=Nervi%2CC&author=Pelicci%2CPG&author=Heinzel%2CT earn?
• What's the profit of https://doi.org/10.1083%2Fjcb.148.6.1239?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Active%20caspases%20and%20cleaved%20cytokeratins%20are%20sequestered%20into%20cytoplasmic%20inclusions%20in%20TRAIL-induced%20apoptosis&journal=J.%20Cell%20Biol.&doi=10.1083%2Fjcb.148.6.1239&volume=148&pages=1239-1254&publication_year=2000&author=MacFarlane%2CM&author=Merrison%2CW&author=Dinsdale%2CD&author=Cohen%2CGM make?
• Learn about the earnings of https://doi.org/10.1126%2Fscience.282.5393.1497
• How much does http://scholar.google.com/scholar_lookup?&title=Requirement%20for%20p53%20and%20p21%20to%20sustain%20G2%20arrest%20after%20DNA%20damage&journal=Science&doi=10.1126%2Fscience.282.5393.1497&volume=282&pages=1497-1501&publication_year=1998&author=Bunz%2CF&author=Dutriaux%2CA&author=Lengauer%2CC&author=Waldman%2CT&author=Zhou%2CS&author=Brown%2CJP&author=Sedivy%2CJM&author=Kinzler%2CKW&author=Vogelstein%2CB rake in every month?
• What's the financial gain of https://doi.org/10.1056%2FNEJM200012283432602?
• How much does http://scholar.google.com/scholar_lookup?&title=Genomic%20aberrations%20and%20survival%20in%20chronic%20lymphocytic%20leukemia&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJM200012283432602&volume=343&pages=1910-1916&publication_year=2000&author=Dohner%2CH&author=Stilgenbauer%2CS&author=Benner%2CA&author=Leupolt%2CE&author=Krober%2CA&author=Bullinger%2CL&author=Dohner%2CK&author=Bentz%2CM&author=Lichter%2CP earn?
• https://doi.org/10.1002%2Fcncr.0680's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Frequency%20and%20type%20of%20serious%20infections%20in%20fludarabine-refractory%20B-cell%20chronic%20lymphocytic%20leukemia%20and%20small%20lymphocytic%20lymphoma%3A%20implications%20for%20clinical%20trials%20in%20this%20patient%20population&journal=Cancer&doi=10.1002%2Fcncr.0680&volume=94&pages=2033-2039&publication_year=2002&author=Perkins%2CJG&author=Flynn%2CJM&author=Howard%2CRS&author=Byrd%2CJC rake in every month?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477713?
• Profit of http://scholar.google.com/scholar_lookup?&title=Unmutated%20Ig%20V%28H%29%20genes%20are%20associated%20with%20a%20more%20aggressive%20form%20of%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1848-1854&publication_year=1999&author=Hamblin%2CTJ&author=Davis%2CZ&author=Gardiner%2CA&author=Oscier%2CDG&author=Stevenson%2CFK
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477712
• Income figures for http://scholar.google.com/scholar_lookup?&title=Ig%20V%20gene%20mutation%20status%20and%20CD38%20expression%20as%20novel%20prognostic%20indicators%20in%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1840-1847&publication_year=1999&author=Damle%2CRN&author=Wasil%2CT&author=Fais%2CF&author=Ghiotto%2CF&author=Valetto%2CA&author=Allen%2CSL&author=Buchbinder%2CA&author=Budman%2CD&author=Dittmar%2CK&author=Kolitz%2CJ&author=Lichtman%2CSM&author=Schulman%2CP&author=Vinciguerra%2CVP&author=Rai%2CKR&author=Ferrarini%2CM&author=Chiorazzi%2CN
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Molecular%20determinants%20of%20response%20to%20TRAIL%20in%20killing%20of%20normal%20and%20cancer%20cells&journal=Clin.%20Cancer%20Res.&volume=6&pages=335-346&publication_year=2000&author=Kim%2CK&author=Fisher%2CMJ&author=Xu%2CSQ&author=el-Deiry%2CWS
• What are the earnings of https://doi.org/10.1046%2Fj.1365-2141.2003.04699.x?
• How much does http://scholar.google.com/scholar_lookup?&title=Chemical%20sensitization%20and%20regulation%20of%20TRAIL-induced%20apoptosis%20in%20a%20panel%20of%20B-lymphocytic%20leukaemia%20cell%20lines&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2003.04699.x&volume=123&pages=921-932&publication_year=2003&author=Kang%2CJ&author=Kisenge%2CRR&author=Toyoda%2CH&author=Tanaka%2CS&author=Bu%2CJ&author=Azuma%2CE&author=KomadaY%2C pull in?
• Find out how much https://doi.org/10.1074%2Fjbc.M910438199 earns monthly
• How much income is http://scholar.google.com/scholar_lookup?&title=Temperature-sensitive%20differential%20affinity%20of%20TRAIL%20for%20its%20receptors.%20DR5%20is%20the%20highest%20affinity%20receptor&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M910438199&volume=275&pages=23319-23325&publication_year=2000&author=Truneh%2CA&author=Sharma%2CS&author=Silverman%2CC&author=Khandekar%2CS&author=Reddy%2CMP&author=Deen%2CKC&author=McLaughlin%2CMM&author=Srinivasula%2CSM&author=Livi%2CGP&author=Marshall%2CLA&author=Alnemri%2CES&author=Williams%2CWV&author=Doyle%2CML earning monthly?
• Financial intake of https://doi.org/10.1182%2Fblood-2003-12-4333
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20myelodysplastic%20syndromes%20with%20valproic%20acid%20alone%20or%20in%20combination%20with%20all-trans%20retinoic%20acid&journal=Blood&doi=10.1182%2Fblood-2003-12-4333&volume=104&pages=1266-1269&publication_year=2004&author=Kuendgen%2CA&author=Strupp%2CC&author=Aivado%2CM&author=Bernhardt%2CA&author=Hildebrandt%2CB&author=Haas%2CR&author=Germing%2CU&author=Gattermann%2CN?
• How much does https://doi.org/10.1097%2F00062752-200207000-00010 earn?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20as%20therapeutic%20targets%20in%20hematologic%20malignancies&journal=Curr.%20Opin.%20Hematol.&doi=10.1097%2F00062752-200207000-00010&volume=9&pages=322-332&publication_year=2002&author=Melnick%2CA&author=Licht%2CJD
• https://doi.org/10.1074%2Fjbc.M410660200's revenue stream
• Get to know http://scholar.google.com/scholar_lookup?&title=Receptor-selective%20mutants%20of%20apoptosis-inducing%20ligand%202L%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20reveal%20a%20greater%20contribution%20of%20death%20receptor%20%28DR%29%205%20than%20DR4%20to%20apoptosis%20signaling&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M410660200&volume=280&pages=2205-2212&publication_year=2005&author=Kelley%2CRF&author=Totpal%2CK&author=Lindstrom%2CSH&author=Mathieu%2CM&author=Billeci%2CK&author=Deforge%2CL&author=Pai%2CR&author=Hymowitz%2CSG&author=Ashkenazi%2CA's earnings
• How much revenue does https://doi.org/10.1038%2F91000 bring in?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20a%20novel%20anti-human%20DR5%20monoclonal%20antibody%20without%20hepatocyte%20cytotoxicity&journal=Nat.%20Med.&doi=10.1038%2F91000&volume=7&pages=954-960&publication_year=2001&author=Ichikawa%2CK&author=Liu%2CW&author=Zhao%2CL&author=Wang%2CZ&author=Liu%2CD&author=Ohtsuka%2CT&author=Zhang%2CH&author=Mountz%2CJD&author=Koopman%2CWJ&author=Kimberly%2CRP&author=Zhou%2CT?
• How much profit does https://doi.org/10.1182%2Fblood.V98.3.795 generate?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=TRAIL%2FApo2L%20ligand%20selectively%20induces%20apoptosis%20and%20overcomes%20drug%20resistance%20in%20multiple%20myeloma%3A%20therapeutic%20applications&journal=Blood&doi=10.1182%2Fblood.V98.3.795&volume=98&pages=795-804&publication_year=2001&author=Mitsiades%2CCS&author=Treon%2CSP&author=Mitsiades%2CN&author=Shima%2CY&author=Richardson%2CP&author=Schlossman%2CR&author=Hideshima%2CT&author=Anderson%2CKC have monthly?
• Revenue of https://doi.org/10.1038%2F364806a0
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Lethal%20effect%20of%20the%20anti-Fas%20antibody%20in%20mice&journal=Nature&doi=10.1038%2F364806a0&volume=364&pages=806-809&publication_year=1993&author=Ogasawara%2CJ&author=Watanabe-Fukunaga%2CR&author=Adachi%2CM&author=Matsuzawa%2CA&author=Kasugai%2CT&author=Kitamura%2CY&author=Itoh%2CN&author=Suda%2CT&author=Nagata%2CS is on a monthly basis
• What's the profit of https://doi.org/10.1038%2F86397?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Differential%20hepatocyte%20toxicity%20of%20recombinant%20Apo2L%2FTRAIL%20versions&journal=Nat.%20Med.&doi=10.1038%2F86397&volume=7&pages=383-385&publication_year=2001&author=Lawrence%2CD&author=Shahrokh%2CZ&author=Marsters%2CS&author=Achilles%2CK&author=Shih%2CD&author=Mounho%2CB&author=Hillan%2CK&author=Totpal%2CK&author=DeForge%2CL&author=Schow%2CP&author=Hooley%2CJ&author=Sherwood%2CS&author=Pai%2CR&author=Leung%2CS&author=Khan%2CL&author=Gliniak%2CB&author=Bussiere%2CJ&author=Smith%2CCA&author=Strom%2CSS&author=Kelley%2CS&author=Fox%2CJA&author=Thomas%2CD&author=Ashkenazi%2CA have monthly?
• How much does https://doi.org/10.1074%2Fjbc.M404541200 generate monthly?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Death%20induction%20by%20recombinant%20native%20TRAIL%20and%20its%20prevention%20by%20a%20caspase%209%20inhibitor%20in%20primary%20human%20esophageal%20epithelial%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M404541200&volume=279&pages=40044-40052&publication_year=2004&author=Kim%2CSH&author=Kim%2CK&author=Kwagh%2CJG&author=Dicker%2CDT&author=Herlyn%2CM&author=Rustgi%2CAK&author=Chen%2CY&author=El-Deiry%2CWS
• What's the monthly money flow for https://doi.org/10.1038%2Fsj.cdd.4401331?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Human%20normal%20hepatocytes%20are%20susceptible%20to%20apoptosis%20signal%20mediated%20by%20both%20TRAIL-R1%20and%20TRAIL-R2&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401331&volume=11&pages=203-207&publication_year=2004&author=Mori%2CE&author=Thomas%2CM&author=Motoki%2CK&author=Nakazawa%2CK&author=Tahara%2CT&author=Tomizuka%2CK&author=Ishida%2CI&author=Kataoka%2CS?
• What's the total monthly financial gain of https://doi.org/10.1158%2F0008-5472.CAN-04-2599?
• How profitable is http://scholar.google.com/scholar_lookup?&title=TRAIL%20inhibits%20tumor%20growth%20but%20is%20nontoxic%20to%20human%20hepatocytes%20in%20chimeric%20mice&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2599&volume=64&pages=8502-8506&publication_year=2004&author=Hao%2CC&author=Song%2CJH&author=Hsi%2CB&author=Lewis%2CJ&author=Song%2CDK&author=Petruk%2CKC&author=Tyrrell%2CDL&author=Kneteman%2CNM?
• Earnings of https://doi.org/10.1074%2Fjbc.M109893200
• How much does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20and%20Bcl-xL%20inhibit%20CD95-mediated%20apoptosis%20by%20preventing%20mitochondrial%20release%20of%20Smac%2FDIABLO%20and%20subsequent%20inactivation%20of%20X-linked%20inhibitor-of-apoptosis%20protein&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M109893200&volume=277&pages=11345-11351&publication_year=2002&author=Sun%2CXM&author=Bratton%2CSB&author=Butterworth%2CM&author=MacFarlane%2CM&author=Cohen%2CGM bring in each month?
• What's the income of https://doi.org/10.1074%2Fjbc.274.8.5053?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Distinct%20caspase%20cascades%20are%20initiated%20in%20receptor-mediated%20and%20chemical-induced%20apoptosis&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.274.8.5053&volume=274&pages=5053-5060&publication_year=1999&author=Sun%2CXM&author=MacFarlane%2CM&author=Zhuang%2CJ&author=Wolf%2CBB&author=Green%2CDR&author=Cohen%2CGM produce monthly?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9058723
• How much does http://scholar.google.com/scholar_lookup?&title=p53%20abnormalities%20in%20B-cell%20prolymphocytic%20leukemia&journal=Blood&volume=89&pages=2015-2023&publication_year=1997&author=Lens%2CD&author=De%20Schouwer%2CPJ&author=Hamoudi%2CRA&author=Abdul-Rauf%2CM&author=Farahat%2CN&author=Matutes%2CE&author=Crook%2CT&author=Dyer%2CMJ&author=Catovsky%2CD bring in each month?
• How much profit does https://doi.org/10.1038%2Fsj.thj.6200325 make?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Characterisation%20of%20TP53%20abnormalities%20in%20chronic%20lymphocytic%20leukaemia&journal=Hematol.%20J.&doi=10.1038%2Fsj.thj.6200325&volume=5&pages=47-54&publication_year=2004&author=Thornton%2CPD&author=Gruszka-Westwood%2CAM&author=Hamoudi%2CRA&author=Atkinson%2CS&author=Kaczmarek%2CP&author=Morilla%2CRM&author=Hilditch%2CBL&author=A%27Hern%2CR&author=Matutes%2CE&author=Catovsky%2CD generate?
• How much profit does https://doi.org/10.1038%2Fsj.leu.2403202 make?
• http://scholar.google.com/scholar_lookup?&title=Design%20and%20standardization%20of%20PCR%20primers%20and%20protocols%20for%20detection%20of%20clonal%20immunoglobulin%20and%20T-cell%20receptor%20gene%20recombinations%20in%20suspect%20lymphoproliferations%3A%20report%20of%20the%20BIOMED-2%20Concerted%20Action%20BMH4-CT98-3936&journal=Leukemia&doi=10.1038%2Fsj.leu.2403202&volume=17&pages=2257-2317&publication_year=2003&author=van%20Dongen%2CJJ&author=Langerak%2CAW&author=Bruggemann%2CM&author=Evans%2CPA&author=Hummel%2CM&author=Lavender%2CFL&author=Delabesse%2CE&author=Davi%2CF&author=Schuuring%2CE&author=Garcia-Sanz%2CR&author=van%20Krieken%2CJH&author=Droese%2CJ&author=Gonzalez%2CD&author=Bastard%2CC&author=White%2CHE&author=Spaargaren%2CM&author=Gonzalez%2CM&author=Parreira%2CA&author=Smith%2CJL&author=Morgan%2CGJ&author=Kneba%2CM&author=Macintyre%2CEA's revenue stream
• How much does https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=references gross monthly?
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20MacFarlane?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20MacFarlane%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Inoue generate monthly?
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Inoue%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20L%20Kohlhaas?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20L%20Kohlhaas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Majid
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Majid%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N%20Harper is on a monthly basis
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N%20Harper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20B%20J%20Kennedy income
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20B%20J%20Kennedy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20J%20S%20Dyer net monthly?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20J%20S%20Dyer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20M%20Cohen?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20M%20Cohen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• https://s100.copyright.com/AppDispatchServlet?title=Chronic%20lymphocytic%20leukemic%20cells%20exhibit%20apoptotic%20signaling%20via%20TRAIL-R1&author=M%20MacFarlane%20et%20al&contentID=10.1038%2Fsj.cdd.4401649©right=Springer%20Nature%20Limited&publication=1350-9047&publicationDate=2005-04-29&publisherName=SpringerNature&orderBeanReset=true's total income per month
• How much profit is https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=citation making per month?
• Financial intake of https://doi.org/10.1007/s12032-023-02276-3
• What's the income generated by https://doi.org/10.1038/s41375-023-02035-3 each month?
• https://doi.org/10.1038/s41418-022-01059-z income
• Earnings of https://doi.org/10.1038/cddis.2017.423
• How much profit does https://doi.org/10.1038/cdd.2015.174 generate?
• https://www.protocols.io/'s revenue stream
• How much money does https://www.natureindex.com/ make?
• How much does http://www.naturechina.com make?
• How much does https://www.natureasia.com/ja-jp bring in each month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk